StockData
ARS Pharmaceuticals, Inc. logo

ARS Pharmaceuticals, Inc. (SPRY) stock

SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$3.65+0.06 (+1.67%)

Close on Nov 17, 2026Market cap $362.98MP/E –Yield –

ARS Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ARS Pharmaceuticals's market cap was $392.78M on Nov 11, 2026, against $942.97M a year earlier. Over the last 5 years it ranged from $94.45M to $1.73B, with a median of $795.39M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$392.78M-65.9%
2025Dec 31, 2025$1.15B+12.4%
2024Dec 31, 2024$1.02B+95.2%
2023Dec 29, 2023$524.96M+71.5%
2022Dec 30, 2022$306.08M+31.2%
2021Dec 31, 2021$233.35M–

More ARS Pharmaceuticals figures

See a number that looks wrong?